window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Digital Health

  • Artificial Intelligence,Clinical Development,Data Management,Digital Health,Healthcare leadership,Pharmaceuticals and therapeutics,Research & Development

    AI and medical affairs strategy set to redefine life sciences in 2026

    Artificial intelligence, shifting healthcare professional behaviour and rising pressure on [...]

    February 18, 2026
  • Clinical Development,Data Management,Digital Health,Movers & Shakers,Technology and platforms

    IgniteData appoints Laura Hilty as CSO and Joe Lengfellner as CPO amid Series A funding close

    IgniteData has appointed Laura Hilty as chief strategy officer and [...]

    February 11, 2026
  • Artificial Intelligence,Clinical Development,Clinical Trials,Digital Health

    PhaseV launches AI enrollment lab to model clinical trial feasibility before protocol lock

    PhaseV has launched a new AI-powered Enrollment Lab designed to [...]

    February 3, 2026
  • Digital Health,Funding,Global health,Mental health,Patient Centricity

    Wellcome awards £5.3m grant to Wysa for adolescent mental health study in India

    Wellcome has awarded £5.3m in funding to digital mental health [...]

    February 3, 2026
  • Chronic diseases,Digital Health,Medical devices,Partnerships & Funding

    M42’s Imperial College London Diabetes & Endocrine Centre and Medtronic to establish Middle East automated insulin delivery centre

    M42’s Imperial College London Diabetes & Endocrine Centre and Medtronic [...]

    February 2, 2026
  • Biotech,Digital Health,Technology and platforms

    Research finds scientists view ELNs as ‘glorified filing cabinets’, driving duplication and shadow AI use

    A new survey by Sapio Sciences has found widespread frustration [...]

    January 30, 2026
  • Clinical Trials,Digital Health,Patient Centricity,Real world evidence,Technology and platforms

    Kayentis and Ametris partner on integrated eCOA and wearable adherence platform

    Kayentis and Ametris have announced a strategic partnership to integrate [...]

    January 30, 2026
  • Digital Health,Healthcare leadership,Medical devices,Mental health,Regulatory Affairs

    Mental health systems strain as demand and funding shifts drive push for multimodal care

    Mental health systems in the US and UK have entered [...]

    January 29, 2026
  • Clinical Development,Digital Health,Patient Centricity,Technology and platforms

    Beauregard Health System unifies post-appointment medication messaging with Artera and DrFirst integration

    Beauregard Health System has integrated Artera’s patient communication platform and [...]

    January 27, 2026
  • Central Nervous System,Digital Health,Medical devices,Patient Centricity,Pharmaceuticals and therapeutics

    NeuroVice seizure oral injury device now available through BlinkRx

    The PATI device from NeuroVice, designed to protect against oral [...]

    January 20, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Regeneron enters radiopharmaceuticals through multi-programme collaboration with Telix in oncology expansion
    Categories: Drug discovery, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Precision medicine, Research & Development, Technology and platforms
  • Pharma firms localise GLP-1 supply chains as shortages and geopolitical risks grow
    Categories: Biomanufacturing, CDMOs & Manufacturing, Drug Development, Manufacturing, Pharmaceuticals and therapeutics, Supply Chain & Logistics
  • Emalex wins US patent for ecopipam ODT as Tourette access program grows
    Categories: Clinical Development, Drug Development, FDA, Neurosciences, Pharmaceuticals and therapeutics, Rare Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top